We invest at the nexus of disruptive technology platforms and healthcare. We focus at seed stage and prefer to be the first institutional investor.
We focus on disruptive technology platforms transforming therapeutics, diagnostics and broader health services.
We look at mainly the US market - the largest with coming disruptive innovations.